Displaying 1–25 of 2568 results for
Why pharma manufacturers shouldn’t get stuck in a comic
Drug Development: Exploring the technologies needed to achieve automatic control of cell culture processes.
A new report shows that the number of FDA approvals for cancer drugs has shot up in the last few decades. What’s behind the rise?
BIO 2019 shows how incremental investments make a global impact
Exploring best-practice manufacturing strategies for highly potent oral solid dosage forms
New approaches to fluid control enhance pharma manufacturing
The definition of pharma innovation isn’t always clear cut
How the use of aseptic split butterfly valve technology can prevent contamination
Pharma Manufacturing's annual Pharma Innovation Award winners offer slices of innovation
Revised GMP guidelines will strengthen emphasis on contamination control, impacting cleanroom performance qualifications
The annual Pharma Innovation Awards are our brand's way of acknowledging the investment pharmaceutical equipment vendors put into developing and improving their products.
As far as M&A deals go, 2019 has started off with a boom.
Lucrative compensation packages for CEOs are certainly not unique to pharma. But many of the industry's top dogs got hefty raises last year, showing it's a good time to be a CEO in pharma.
How the pharma industry's big ideas are impacting sterile manufacturing
There is a flourishing biosimilar industry in Latin America, with its own research, development, production and commercialization capacity.
A wave of incoming anti-inflammatories and gene therapies that could make it big
It’s important to consider how product drift will impact biosimilars
FDA looks to improve transparency and predictability for generic drug applicants.
Quality & Compliance: “Flawless” may not exist on the plant floor, but reviewing your quality process can save money and lives.
Automation & Control: Single-use technologies offer multiple benefits for those who can overcome instrumentation challenges.
How those in the outsourcing sector can be more prepared to meet shifting customer demands as the industry continues to evolve.
A Q&A about the FDA DSCSA Pilot Program Pilot
CPhI N. America's keynote speaker explains what bipartisan bickering means for pharma
Shared pursuits might lead to bigger rewards
Eliminating siloed systems in favor of streamlined applications allows for greater agility and stronger collaboration, enabling pharma to meet the new quality management demands